RxDoctor Payments Data

Jody Hostert

Psychiatric/Mental Health · Hiawatha, IANPI 1730149121

Payments from drug & device makers

$3,032in general payments, 2019–2025

Across 193 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$857
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$475
  • Alkermes, Inc.$275
  • Supernus Pharmaceuticals, Inc.$252
  • Axsome Therapeutics, Inc.$166
  • Johnson & Johnson$132
  • plus $874 from 15 others

What the payments were for

  • Food & beverage$3,032100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,032 in reported general payments places this provider in the 80th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$15,258
Medicare patients
30
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl25$35,956
Lurasidone Hcl11$19,488
Asenapine Maleate51$12,987
Bupropion XlBupropion Hcl108$4,086
Lisdexamfetamine Dimesylate14$3,567
Divalproex Sodium ErDivalproex Sodium33$1,175
Aripiprazole44$1,091
Venlafaxine Hcl ErVenlafaxine Hcl55$1,056
Quetiapine Fumarate27$1,018
Duloxetine Hcl55$918
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine29$859
Olanzapine30$759
Trazodone Hcl87$749
Methylphenidate Hcl25$643
Escitalopram Oxalate61$545

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$857$35,95625 claims
Almatica Pharma LLCSertraline Hcl$63$12426 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Hiawatha

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →